Dermatology · Voorhees, NJ
NPI
1518034628
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
701 Cooper Rd, Suite #13
Voorhees, NJ, 08043
Phone (856) 344-2849
Groups this clinician bills Medicare through
Medicare paid, 2024
$333K
4,983 services
Medicare patients, 2024
713
Average age 74
Drug cost, 2024
$2.3M
1,590 prescriptions
Company payments, 2025
$3,793
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David H Finkelstein was code 17003 (destruction skin lesion), 1,128 times for 302 patients. In total David H Finkelstein billed 4,983 services in 58 codes, and Medicare paid $333K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,128 | 302 | $5.45 | $6,148 |
| 99213 Office E&M - Established | Office | 864 | 582 | $63.14 | $55K |
| 17000 Destruction Skin Lesion | Office | 512 | 391 | $43.68 | $22K |
| 11102 Skin Biopsy | Office | 186 | 157 | $74.35 | $14K |
| 99203 Office E&M - New | Office | 137 | 137 | $74.99 | $10K |
| 17110 Destruction Skin Lesion | Office | 125 | 96 | $82.32 | $10K |
| 17004 Destruction Skin Lesion | Office | 47 | 35 | $128.12 | $6,021 |
| 99212 Office E&M - Established | Office | 40 | 35 | $42.22 | $1,689 |
| 96372 Injection Administration | Office | 32 | 11 | $12.24 | $392 |
| 10040 Removal or Shaving of Skin Growth | Office | 28 | 28 | $75.22 | $2,106 |
| 11103 Skin Biopsy | Office | 27 | 26 | $40.77 | $1,101 |
| 17262 Destruction Skin Lesion | Office | 23 | 22 | $135.16 | $3,109 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 22 | 16 | $0.69 | $15.09 |
| 12032 Wound Repair - All Levels | Office | 21 | 20 | $238.16 | $5,001 |
| 11900 Skin | Office | 19 | 16 | $28.67 | $545 |
By year: 2022 $150K for 3,106 services; 2023 $156K for 3,161 services; 2024 $333K for 4,983 services.
Medicare prescription drug claims, 2024
In 2024, the drug David H Finkelstein prescribed most often to Medicare patients was Ketoconazole, with 329 prescriptions and refills. In total David H Finkelstein wrote 1,590 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 329 | 380 | 151 | $7,711 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 200 | 205 | 130 | $11K |
| Dupixent Pen Dupilumab | 196 | 196 | 25 | $770K |
| Triamcinolone Acetonide Generic | 151 | 159 | 98 | $1,648 |
| Doxycycline Monohydrate Generic | 115 | 129 | 59 | $2,836 |
| Metronidazole Generic | 74 | 78 | 36 | $3,432 |
| Tretinoin Generic | 68 | 70 | 20 | $3,134 |
| Clindamycin Phosphate Generic | 46 | 46 | 19 | $1,638 |
| Tacrolimus Generic | 37 | 37 | 28 | $2,235 |
| Terbinafine Hcl Generic | 34 | 80 | 20 | $779 |
| Mupirocin Generic | 33 | 34 | 30 | $226 |
| Valacyclovir Valacyclovir Hcl | 33 | 41 | 20 | $722 |
| Otezla Apremilast | 28 | 28 | Under 11 | $134K |
| Cimzia (2 Pack) Certolizumab Pegol | 22 | 22 | Under 11 | $292K |
| Spironolactone Generic | 20 | 36 | Under 11 | $229 |
Brand drugs: 466 claims; generic drugs: 1,124 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David H Finkelstein $3,793 ($3,793 in general payments such as food, travel and fees) from 18 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $708.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 49 | $708 |
| Abbvie Inc. ABBV | 33 | $466 |
| Almirall LLC | 32 | $420 |
| E.R. Squibb & Sons, L.L.C. BMY | 40 | $369 |
| LEO Pharma Inc. | 26 | $322 |
| Organon LLC OGN | 33 | $297 |
| UCB, Inc. UCB.BR | 14 | $183 |
| Pfizer Inc. PFE | 13 | $174 |
| Novartis Pharmaceuticals Corporation NVS | 16 | $173 |
| Galderma Laboratories, L.P. GALD.SW | 14 | $153 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.